Opus Genetics, INC. (IRD) SEC Filings — 2025
28 SEC filings for Opus Genetics, INC. (IRD) in 2025.
Filings
- Opus Genetics Relocates Principal Executive Offices — 8-K · Dec 19, 2025
- Opus Genetics' Loss Widens Amid Gene Therapy Push, Warrant Costs — 10-Q · Nov 12, 2025
- Opus Genetics Files 8-K — 8-K · Nov 6, 2025
- Opus Genetics Files 8-K with Regulatory Updates — 8-K · Sep 30, 2025
- Opus Genetics Files 8-K on Officer/Director Changes — 8-K · Sep 2, 2025
- Opus Genetics Reports Unregistered Equity Sales — 8-K · Aug 25, 2025
- Opus Genetics Narrows Q2 Loss, Boosted by Viatris Revenue — 10-Q · Aug 13, 2025
- Opus Genetics Enters Material Definitive Agreement — 8-K · Jul 23, 2025
- Opus Genetics Files 8-K — 8-K · Jun 26, 2025
- Opus Genetics Files 8-K on Leadership and Compensation Changes — 8-K · Jun 25, 2025
- Opus Genetics Files 8-K: Reg FD & Financials — 8-K · Jun 23, 2025
- Opus Genetics Enters Material Definitive Agreement — 8-K · Jun 20, 2025
- Opus Genetics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Opus Genetics Files 8-K on Shareholder Vote Matters — 8-K · May 1, 2025
- Opus Genetics Files Definitive Proxy Materials — DEFA14A · Apr 14, 2025
- Opus Genetics Files Proxy Materials — DEFA14A · Apr 11, 2025
- Opus Genetics Files Proxy Materials — DEFA14A · Apr 10, 2025
- Opus Genetics Files Proxy Materials — DEFA14A · Apr 7, 2025
- Opus Genetics Terminates Material Definitive Agreement — 8-K · Apr 4, 2025
- Opus Genetics Files 2024 10-K — 10-K · Mar 31, 2025
- Opus Genetics Files 8-K on Equity Sales — 8-K · Mar 24, 2025
- Opus Genetics Files 8-K on Operations — 8-K · Mar 20, 2025
- Opus Genetics Files 8-K for Bylaw Amendments & Financials — 8-K · Mar 20, 2025
- Opus Genetics Files 8-K for Other Events — 8-K · Mar 4, 2025
- Opus Genetics Announces Board and Executive Changes — 8-K · Jan 24, 2025
- Opus Genetics (fka Ocuphire Pharma) Files 8-K — 8-K · Jan 23, 2025
- Opus Genetics Files 8-K — 8-K · Jan 14, 2025
- Opus Genetics Files 8-K/A Amendment — 8-K/A · Jan 7, 2025